Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 64, Issue 1, 2005, Pages 52-55

  Breedveld, F C ^a   Han, C ^b   Bala, M ^b   Van Der Heijde, D ^c   Baker, D ^b   Kavanaugh, A F ^d   Maini, R N ^e   Lipsky, P E ^f  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTOCOR INC   (United States)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHOTREXATE;

AGE; ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; HUMAN; JOINT INJURY; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PHYSICAL DISABILITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METHOTREXATE; PROGNOSIS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 11344263145     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.017160     Document Type: Article

References (23)

1. Kavanaugh AF, Lipsky PE. Rheumatoid arthritis. In: Rich RR, Fleisher TA, Schwartz B, Shearer W, et al. Clinical immunology: principles and practice. St Louis: Mosby Year Boob, 1996:1093-116.
2. Wolfe F, Hawley DJ. The long-term outcomes of rheumatoid arthritis: work disability; a prospective 18 year study of 823 patients. J Rheumatol 1998;25:2108-17.
3. Clarke AE, St-Pierre Y, Joseph L, Penrod JT, Sibley MH, Genant HK. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs. J Rheumatol 2001;28:2416-24.
4. Escalante A, del Rincon I. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum 1999;42:1712-21.
5. Molenaar ET, Voskuyl AE, Dijkmans BA. Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission. J Rheumalol 2002;29:267-70.
6. Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JMW. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999;42:1854-60.
7. Guillemin F, Briancon S, Pourel J. Functional disability in rheumatoid arthritis: two different models in early and established disease. J Rheumatol 1992;19:366-9.
8. Guillemin F, Suurmeijer T, Krol B, Bombardier C, Briancon S, Doeglas D, et al. Functional disability in early rheumatoid arthritis: description and risk factors. J Rheumatol 1994;21:1051-5.
9. van Leeuwen MA, van der Heijde DMFM, van Rijswijk MH, Houtman PM, van Riel PLCM, van de Putte LBA, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994;21:425-9.
10. van der Heijde A, Remme CA, Hofman DM, Jacobs JWG, Bijlsma JWJ. Prediction or progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995;38:1466-74.
11. Kirwan JR. Conceptual issues in scoring radiographic progression in rheumatoid arthritis. J Rheumatol 1999;26:720-5.
12. Maini R, St Clair EW, Breedveld F, Kalden J, Weisman M, Smolen J, et al. Infliximab (chimeric anti-tumour necrosis factor-α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet 1999;354:1932-9.
13. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
14. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
15. Ramey DR, Raynauld JP, Fries JF. The health assessment questionnaire 1992: status and review. Arthritis Care Res 1992;5:119-29.
16. van der Heijde DM, van Leeuwen MA, van Riel PL, Koster AM, van't Hof MA, van Rijswijk MH, et al. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 1992;35:26-34.
17. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003;1:20-6.
18. th ed. Iowa City: Iowa State University Press, 1980.
19. Kalden JR. Expanding role of biologic agents in rheumatoid arthritis. J Rheumatol 2002;29(suppl 66):27-37.
20. van der Heijde D. Radiographic progression in rheumatoid arthritis: does it reflect outcome? Does it reflect treatment? Ann Rheum Dis 2001;60(suppl 3):iii47-50.
21. Sokka T, Pincus T. Markers for work disability in rheumatoid arthritis. J Rheumatol 2001;28:1718-22.
22. Choi HK, Wolfe F. Radiologic progression and mortality [abstract]. Arthritis Rneum 2001;44(suppl 9):S221.
23. Kavanaugh AF, Han C, Bala M, et al. Improvement in functional status results in increased employability and reduced costs of RA: analysis of the minimum clinically important difference in health assessment questionnaire in the AHRACT study [abstract]. Arthritis Rheum 2002;46(suppl 9):S575.